Montégut, C., Falandry, C., Cinieri, S., Cropet, C., Montane, L., Rousseau, F., . . . Sabatier, R. (2024). Safety and quality of life with maintenance olaparib plus bevacizumab in older patients with ovarian cancer: Subgroup analysis of PAOLA‑1/ENGOT-ov25. The oncologist. https://doi.org/10.1093/oncolo/oyae322
Chicago Style (17th ed.) CitationMontégut, Coline, et al. "Safety and Quality of Life with Maintenance Olaparib Plus Bevacizumab in Older Patients with Ovarian Cancer: Subgroup Analysis of PAOLA‑1/ENGOT-ov25." The Oncologist 2024. https://doi.org/10.1093/oncolo/oyae322.
MLA (9th ed.) CitationMontégut, Coline, et al. "Safety and Quality of Life with Maintenance Olaparib Plus Bevacizumab in Older Patients with Ovarian Cancer: Subgroup Analysis of PAOLA‑1/ENGOT-ov25." The Oncologist, 2024, https://doi.org/10.1093/oncolo/oyae322.